Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 20/20 | 0.55 |
| ▸ | DPP8 | Q6V1X1 | 5/20 | 0.52 |
| ▸ | DPP9 | Q86TI2 | 5/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3896390 | 1.00 | DPP4 (0.55) | DPP4DPP8DPP9 | |
| SCHEMBL3897026 | 1.00 | DPP4 (0.55) | DPP4DPP8DPP9 | |
| SCHEMBL3898036 | 1.00 | DPP4 (0.55) | DPP4DPP8DPP9 | |
| SCHEMBL3896522 | 0.82 | DPP4 (0.56) | DPP4DPP8DPP9 | |
| SCHEMBL3969372 | 0.82 | DPP4 (0.56) | DPP4DPP8DPP9 | |
| SCHEMBL3905944 | 0.81 | DPP4 (0.57) | DPP4DPP8DPP9 | |
| SCHEMBL3905945 | 0.81 | DPP4 (0.57) | DPP4DPP8DPP9 | |
| SCHEMBL3906880 | 0.81 | DPP4 (0.57) | DPP4DPP8DPP9 | |
| SCHEMBL13868010 | 0.80 | DPP4 (0.57) | DPP4DPP8DPP9 | |
| SCHEMBL3894797 | 0.79 | DPP4 (0.65) | DPP4DPP8DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7538128-B2 | Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing them | GLENMARK PHARMACEUTICALS S.A. (CH) | 2009-05-26 | — | — | US | disclosed |
| US-20070238728-A1 | NOVEL DIPEPTIDYL PEPTIDASE IV INHIBITORS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | GLENMARK PHARMACEUTICALS S.A. (CH) | 2007-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070238728-A1 | NOVEL DIPEPTIDYL PEPTIDASE IV INHIBITORS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | DPP4, DPP3, DPP7 | DPP4 1/4885DPP8 5/4885DPP9 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.